STORZ And BICKEL Announces Certification Of Medical Vaporizers
When it comes to cannabis consumption devices, one brand stands above all others. That brand is, of course, STORZ & BICKEL. The company’s iconic Volcano vaporizer revolutionized the way that people consume cannabis around the globe over two decades ago, and the flagship device continues to stand the test of time.
The company has since expanded its gadget offerings, and STORZ & BICKEL’s devices are often touted by members of the medical community as being the best devices to use if you are a suffering medical cannabis patient. Recently, the company’s devices received a new certification which further establishes them as some of the top devices for patients. Below is more information about it via a company news release:
TUTTLINGEN, Germany: STORZ & BICKEL GmbH (“STORZ & BICKEL”), the world’s leading manufacturer of high quality and medically certified vaporizers for cannabis and subsidiary of Canopy Growth Corporation (TSX: WEED) (Nasdaq: CGC), today announced the certification of its premium devices VOLCANO MEDIC 2 and MIGHTY+ MEDIC according to the new EU regulation for medical devices (“MDR “) known.
The new MDR regulations contain stricter quality requirements for medical devices manufactured or imported into the EU than the previous MDD (Medical Devices Directive).
The comprehensive certification process was carried out by TÜV SÜD, a renowned provider of certification, auditing and testing services. As part of the audit, several strict criteria of the standard (DIN) EN ISO 13485:2016 were evaluated, which require defined processes and the documentation of the quality management system of the audited body, the European Directive 93/42/EEC (MDD) and the European Regulation for Medical Devices (EU) 2017/745 – Annex IX Chapter I and III. In addition, the exam covered the MDSAP with country-specific requirements for Australia (TGA), Canada (HC) and the United States (FDA). STORZ & BICKEL passed the test with excellent results and no complaints.
“As the world’s leading manufacturer of medically certified cannabis vaporizers, we recognize the great responsibility we have towards our patients and we are very proud of this achievement,” said Juergen Bickel, Founder and Managing Director of STORZ & BICKEL. “We continue to build on our strong foundation of leading device design and rigorous quality assurance and control standards to ensure the availability of our world-class medical vaporizers to patients worldwide . ”
STORZ & BICKEL is expected to launch the VOLCANO MEDIC 2 and the MIGHTY+ MEDIC with MDR certification in August – once again setting a new industry standard and reaffirming the company’s commitment to exceptional quality.
You can find more information about STORZ & BICKEL at www.storz-bickel.com .
Information on STORZ & BICKEL GmbH
STORZ & BICKEL GmbH is a global leader in the manufacture of high quality and medically certified vaporizers for cannabis. With quality, innovation and compliance, the company has consistently delivered exceptional products that meet the highest industry standards. Based in Tuttlingen, Germany, STORZ & BICKEL is driving the advancement of vaporization technology, providing a safe and efficient means of consuming cannabis for medicinal purposes.
About Canopy Growth
Canopy Growth Corporation (“Canopy Growth”) is a leading North American cannabis and consumer products company committed to unleashing the power of cannabis to improve lives.
Through a relentless commitment to its customers, Canopy Growth delivers innovative products with a focus on premium and mainstream cannabis brands such as Doja, 7ACRES, Tweed and Deep Space. Canopy Growth’s CPG portfolio includes sugar-free sports drink brand BioSteel, targeted 24-hour skincare and wellness solutions from This Works, gourmet wellness products from Martha Stewart CBD, and category-defining vaporization technology from Germany’s Storz & Bickel.
Canopy Growth has built an extensive ecosystem to capitalize on opportunities in the U.S. THC market. These include rights to Acreage Holdings, a vertically integrated multi-state cannabis operator with primary operations in densely populated states in the Northeast. As well as Wana Brands , a leading brand of edibles in North America, and Jetty Extracts, a California-based manufacturer of high-quality cannabis extracts and a pioneer of clean vape technology.
In addition to its best-in-class products, Canopy Growth leads the industry in its commitment to social justice, responsible consumption and community reinvestment – pioneering a future where cannabis is understood and embraced for its potential to contribute to greater wellbeing and a better life.
Visit www.canopygrowth.com for more information .
Cautionary Statements About Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995 and “forward-looking information” within the meaning of theapplicable Canadian securities laws. Often, but not always, forward-looking statements and information can be identified by the use of words such as “plans,” “expects” or “does not expect,” “is expected,” “estimates,” “intends,” “foresees” or “does not anticipate,” or “believes,” or variations of such words and phrases, or state that certain actions, events, or results “may,” “could,” “would,” “may” or “will” occur or be achieved. Forward-looking statements or information involve known and unknown risks, uncertainties and other factors that could cause the actual results, The performance or achievements of Canopy Growth or its subsidiaries may differ materially from any future results, performance or achievements expressed or implied by the forward-looking statements or information contained in this press release. Examples of such statements and uncertainties include statements regarding new product launches as part of MDR certification, including the timing, expected outcome and quality of such new product launches, and expectations regarding other economic, business and/or competitive factors.
including changes in financial and stock markets and the impact of elevated rates of inflation; legal and regulatory risks in the cannabis industry, including the global regulatory environment and enforcement of cannabis-related regulations; reducing the concentration of the active substance; political risks and risks related to regulatory changes; risks related to anti-money laundering laws; Compliance with extensive government regulations and the interpretation of various laws, regulations and policies; public opinion and perception of the cannabis industry; and other risks contained in Canopy Growth’s public records,www.sedar.com and on the United States Securities and Exchange Commission through EDGAR at www.sec.gov/edgar , including under the heading “Risk Factors” in Canopy Growth’s Annual Report on Form 10-K for the year ended March 31, 2023.
With respect to the forward-looking statements and information, Canopy Growth has made such statements and information based on certain assumptions it believes to be reasonable at the time. Although Canopy Growth believes that the assumptions and factors used in preparing the forward-looking information or forward-looking statements contained in this press release are reasonable, undue reliance should not be placed on such information. There can be no assurance that these events will occur in the time periods indicated or at all. Should one or more of the aforementioned risks or uncertainties materialize, or should the assumptions on which the forward-looking information is based prove to be incorrect, actual results may differ materially from the intended, planned, anticipated, believed, estimated or expected results described herein. Although Canopy Growth has attempted to identify important risks, uncertainties and factors that could cause actual results to differ materially, there may be other factors that cause results not to be as anticipated, estimated or intended. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and neither STORZ & BICKEL nor Canopy Growth undertakes any obligation to publicly update such forward-looking information or forward-looking statements to reflect new information,
Media contact: Vatra Krasniqi , Head of Marketing and Communications, +49 7461 96970735, Vatra.krasniqi@storz-bickel.com ; Laura Nadeau , Manager, Communications, media@canopygrowth.com ; Tyler Burns , Director, Investor Relations, Tyler.Burns@canopygrowth. com
SOURCE Canopy Growth Corporation; Storz & Bickel